04
Precision Oncology Intelligence
Transforms molecular profiling into actionable therapeutic decisions. Built for tumor boards, therapy matching, biomarker analysis and longitudinal monitoring across comprehensive cancer care.
01
Comprehensive Genomic Profiling
Somatic mutations, CNVs, fusions and biomarkers (TMB, MSI, HRD, PD-L1) unified in a single oncology profile.
02
AI Therapy Matching
Evidence-tier ranked drug recommendations across NCCN, SBOC and ANVISA labels with resistance detection.
03
Molecular Tumor Board
Integrated MTB with multi-center sessions, consensus voting, slide generation and meeting minutes.
04
Liquid Biopsy & MRD
Serial ctDNA tracking with VAF dynamics, post-surgical surveillance and clonal evolution analysis.
05
Mutational Signatures
COSMIC v3.4 NNLS decomposition across 12 SBS references with etiology and therapeutic implications.
| Capability | OncoPrecision | Foundation Medicine |
|---|---|---|
| Therapy matching | AI, 9 evidence tiers, NCCN+SBOC+ANVISA | Panel-based, FDA labels only |
| Tumor board | Integrated, multi-center, consensus voting | External, PDF-based |
| Liquid biopsy | Serial ctDNA, MRD, resistance | Single timepoint |
| Mutational signatures | COSMIC v3.4, 12 SBS references | Basic TMB only |
| Companion diagnostics | FDA + ANVISA + EMA | FDA only |
| Pharmacogenomics | 5 oncology PGx genes, CPIC+DPWG | Not included |
| Brazilian compliance | ANVISA, SBOC, REBEC, LGPD | Not available |
33
Computational engines
Platform spec, 2026
228+
API endpoints
Across 50 route modules
9
Evidence tiers
AI therapy matching